Enzene Biosciences, Ltd., a global biotech company based in Pune, India, will invest $50 million to open a state-of-the-art biopharmaceutical manufacturing plant in New Jersey. Operations in the new facility, located on the Princeton West Innovation Campus in Hopewell, are expected to begin in June 2024. It will be the company’s first location outside of India.
As a Contract Development and Manufacturing Organization (CDMO), Enzene Biosciences, a subsidiary of Alkem Laboratories, Ltd., provides services to global pharmaceutical companies, partnering with them in their drug development and manufacturing processes. As part of Enzene’s expansion plans in New Jersey, the company will initially hire 50 employees and grow to 300 employees.
